• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期白藜芦醇补充作为中风的二级预防。

Long-Term Resveratrol Supplementation as a Secondary Prophylaxis for Stroke.

机构信息

Pharmacy Department, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania.

Preclinical Disciplines Department, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania.

出版信息

Oxid Med Cell Longev. 2018 Mar 18;2018:4147320. doi: 10.1155/2018/4147320. eCollection 2018.

DOI:10.1155/2018/4147320
PMID:29743980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5878880/
Abstract

Stroke is a leading cause of mortality worldwide, as well as a source of long-term disabilities and huge socioeconomic costs. This study investigates the effects of resveratrol, an antioxidant supplement, on blood pressure, weight status, glucose, and lipid profile in patients who had a stroke in the last 12 months. Two hundred and twenty-eight patients were divided into three groups: group I received only allopathic treatment (control group), while groups II and III received allopathic treatment with a daily supplementation of oral resveratrol (100 and 200 mg, resp.) for 12 months. In all groups, the changes of the studied parameters were monitored at 6 and 12 months from the initial evaluation. In groups II and III, resveratrol induced significant changes ( < 0.05) in the blood pressure, body mass index, as well as all parameters of the lipid profile, and glucose (in nondiabetic patients), compared to the control group. The supplementation of the allopathic treatment with resveratrol had a beneficial effect on all monitored parameters, which serve as major risk factors for stroke.

摘要

脑卒中是全球范围内主要的致死病因之一,也是导致长期残疾和巨大社会经济成本的一个因素。本研究旨在探讨白藜芦醇(一种抗氧化补充剂)对过去 12 个月内发生脑卒中的患者的血压、体重状况、血糖和血脂谱的影响。228 名患者被分为三组:I 组仅接受传统医学治疗(对照组),而 II 组和 III 组在接受传统医学治疗的同时,每天分别补充 100 和 200mg 的白藜芦醇,持续 12 个月。在所有组中,在初始评估后 6 个月和 12 个月监测研究参数的变化。与对照组相比,II 组和 III 组的白藜芦醇使血压、体重指数以及血脂谱和血糖(在非糖尿病患者中)的所有参数均发生显著变化(<0.05)。与传统医学治疗相比,白藜芦醇的补充对所有监测到的参数都有有益的影响,这些参数是脑卒中的主要危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5c9/5878880/0fcc54395225/OMCL2018-4147320.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5c9/5878880/0fcc54395225/OMCL2018-4147320.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5c9/5878880/0fcc54395225/OMCL2018-4147320.001.jpg

相似文献

1
Long-Term Resveratrol Supplementation as a Secondary Prophylaxis for Stroke.长期白藜芦醇补充作为中风的二级预防。
Oxid Med Cell Longev. 2018 Mar 18;2018:4147320. doi: 10.1155/2018/4147320. eCollection 2018.
2
Anti-inflammatory properties of resveratrol in the retinas of type 2 diabetic rats.白藜芦醇对2型糖尿病大鼠视网膜的抗炎特性
Clin Exp Pharmacol Physiol. 2015 Jan;42(1):63-8. doi: 10.1111/1440-1681.12326.
3
The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.白藜芦醇补充剂对非酒精性脂肪性肝病患者心血管危险因素的影响:一项随机、双盲、安慰剂对照研究。
Br J Nutr. 2015 Sep 14;114(5):796-803. doi: 10.1017/S0007114515002433. Epub 2015 Aug 3.
4
One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease.为期一年的富含白藜芦醇的葡萄提取物补充剂可调节 2 型糖尿病和高血压合并冠心病患者外周血单个核细胞中与炎症相关的 microRNAs 和细胞因子的表达。
Pharmacol Res. 2013 Jun;72:69-82. doi: 10.1016/j.phrs.2013.03.011. Epub 2013 Apr 1.
5
Resveratrol supplementation: Where are we now and where should we go?补充白藜芦醇:我们现在处于什么阶段,又该何去何从?
Ageing Res Rev. 2015 May;21:1-15. doi: 10.1016/j.arr.2015.01.002. Epub 2015 Jan 24.
6
Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.补充白藜芦醇可改善非酒精性脂肪性肝病患者的炎症生物标志物。
Nutr Res. 2014 Oct;34(10):837-43. doi: 10.1016/j.nutres.2014.09.005. Epub 2014 Sep 23.
7
Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice.白藜芦醇可降低小鼠脑缺血再灌注诱导的基质金属蛋白酶-9升高水平。
Life Sci. 2006 Apr 25;78(22):2564-70. doi: 10.1016/j.lfs.2005.10.030.
8
Resveratrol Supplementation in Schizophrenia Patients: A Randomized Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors.白藜芦醇补充剂用于精神分裂症患者:一项评估血清葡萄糖和心血管危险因素的随机临床试验
Nutrients. 2016 Jan 29;8(2):73. doi: 10.3390/nu8020073.
9
Resveratrol Partially Suppresses Inflammatory Events but Does not Affect Stroke Onset in Stroke-Prone Spontaneously Hypertensive Rats.白藜芦醇部分抑制炎症反应,但不影响易卒中型自发性高血压大鼠的卒中发作。
J Atheroscler Thromb. 2015;22(9):958-70. doi: 10.5551/jat.27789. Epub 2015 Apr 7.
10
Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults.长期服用白藜芦醇可改善健康肥胖成年人的肱动脉血流介导的扩张。
J Hypertens. 2013 Sep;31(9):1819-27. doi: 10.1097/HJH.0b013e328362b9d6.

引用本文的文献

1
Oxidative Stress and Nutritional Antioxidants in Renal Diseases: A Narrative Review.肾脏疾病中的氧化应激与营养抗氧化剂:一篇叙述性综述
Antioxidants (Basel). 2025 Jun 20;14(7):757. doi: 10.3390/antiox14070757.
2
Time Does Matter: The Cellular Response to Resveratrol Varies Depending on the Exposure Duration.时间至关重要:细胞对白藜芦醇的反应因暴露持续时间而异。
Int J Mol Sci. 2025 Jun 10;26(12):5542. doi: 10.3390/ijms26125542.
3
Traditional, complementary, and integrative medicine in the management of ischemic stroke: a narrative review.

本文引用的文献

1
Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure.白藜芦醇可改善心力衰竭患者的运动能力和骨骼肌氧化能力。
Am J Physiol Heart Circ Physiol. 2017 Apr 1;312(4):H842-H853. doi: 10.1152/ajpheart.00455.2016. Epub 2017 Feb 3.
2
The effect of resveratrol on hypertension: A clinical trial.白藜芦醇对高血压的影响:一项临床试验。
Exp Ther Med. 2017 Jan;13(1):295-301. doi: 10.3892/etm.2016.3958. Epub 2016 Dec 6.
3
Antidiabetic Effects of Resveratrol: The Way Forward in Its Clinical Utility.
传统医学、补充医学和整合医学在缺血性卒中管理中的应用:一篇叙述性综述
Front Pharmacol. 2025 May 30;16:1561688. doi: 10.3389/fphar.2025.1561688. eCollection 2025.
4
Resveratrol's Pro-Apoptotic Effects in Cancer Are Mediated Through the Interaction and Oligomerization of the Mitochondrial VDAC1.白藜芦醇在癌症中的促凋亡作用是通过线粒体电压依赖性阴离子通道1(VDAC1)的相互作用和寡聚化介导的。
Int J Mol Sci. 2025 Apr 22;26(9):3963. doi: 10.3390/ijms26093963.
5
A comprehensive review on the neuroprotective potential of resveratrol in ischemic stroke.白藜芦醇对缺血性中风神经保护潜力的综合综述。
Heliyon. 2024 Jul 5;10(14):e34121. doi: 10.1016/j.heliyon.2024.e34121. eCollection 2024 Jul 30.
6
Rhoa/ROCK, mTOR and Secretome-Based Treatments for Ischemic Stroke: New Perspectives.基于Rhoa/ROCK、mTOR和分泌组的缺血性中风治疗:新视角。
Curr Issues Mol Biol. 2024 Apr 18;46(4):3484-3501. doi: 10.3390/cimb46040219.
7
Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities.白藜芦醇在人类健康管理中的应用:我们已经走了多远?系统综述白藜芦醇临床试验,以突显差距和机遇。
Int J Mol Sci. 2024 Jan 6;25(2):747. doi: 10.3390/ijms25020747.
8
Neuroprotective Potential of Flavonoids in Brain Disorders.黄酮类化合物在脑部疾病中的神经保护潜力
Brain Sci. 2023 Aug 29;13(9):1258. doi: 10.3390/brainsci13091258.
9
New insights into Sirt1: potential therapeutic targets for the treatment of cerebral ischemic stroke.Sirt1的新见解:治疗脑缺血性中风的潜在治疗靶点
Front Cell Neurosci. 2023 Aug 9;17:1228761. doi: 10.3389/fncel.2023.1228761. eCollection 2023.
10
Application of Robotic Recovery Techniques to Stroke Survivors-Bibliometric Analysis.机器人康复技术在中风幸存者中的应用——文献计量分析
J Pers Med. 2022 Dec 14;12(12):2066. doi: 10.3390/jpm12122066.
白藜芦醇的抗糖尿病作用:其临床应用的未来之路。
J Diabetes Res. 2016;2016:9737483. doi: 10.1155/2016/9737483. Epub 2016 Dec 5.
4
Resveratrol and diabetes: from animal to human studies.白藜芦醇与糖尿病:从动物研究到人体研究
Biochim Biophys Acta. 2015 Jun;1852(6):1145-54. doi: 10.1016/j.bbadis.2014.10.013. Epub 2014 Oct 27.
5
Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice.白藜芦醇通过激活 AMPK 和抑制 RhoA/ROCK 预防 AngII 诱导的高血压。
Hypertens Res. 2014 Sep;37(9):803-10. doi: 10.1038/hr.2014.90. Epub 2014 Jun 26.
6
Mitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioning.线粒体活性氧:缺血/再灌注与预处理中的双刃剑
Redox Biol. 2014 Jun 2;2:702-14. doi: 10.1016/j.redox.2014.05.006. eCollection 2014.
7
Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1α axis.白藜芦醇诱导 mdx 小鼠肌肉中慢氧化表型的表达,同时增强了 SIRT1-PGC-1α 轴的活性。
Am J Physiol Cell Physiol. 2014 Jul 1;307(1):C66-82. doi: 10.1152/ajpcell.00357.2013. Epub 2014 Apr 23.
8
Effects of resveratrol on obesity-related inflammation markers in adipose tissue of genetically obese rats.白藜芦醇对遗传性肥胖大鼠脂肪组织中肥胖相关炎症标志物的影响。
Nutrition. 2013 Nov-Dec;29(11-12):1374-80. doi: 10.1016/j.nut.2013.04.014. Epub 2013 Sep 5.
9
Using Effect Size-or Why the P Value Is Not Enough.使用效应量——为何P值并不足够。
J Grad Med Educ. 2012 Sep;4(3):279-82. doi: 10.4300/JGME-D-12-00156.1.
10
Resveratrol improves vascular function in patients with hypertension and dyslipidemia by modulating NO metabolism.白藜芦醇通过调节一氧化氮代谢改善高血压和血脂异常患者的血管功能。
Hypertension. 2013 Aug;62(2):359-66. doi: 10.1161/HYPERTENSIONAHA.111.01009. Epub 2013 Jun 10.